Previous studies have demonstrated that the binding of PDPN to its ligand CLEC-2 can contribute to cancer tumorigenesis, yet the function of the PDPN/CLEC-2 axis in CRC is unclear. The gene discussed is PDPN; the disease is colorectal carcinoma.